Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × Octreotide × Clear all

NCT04871204 2024-10-31

OTIS

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Weight Loss